{"meshTags":["GTP Phosphohydrolases","Mutation","Drug Screening Assays, Antitumor","Neurofibromin 1","Membrane Proteins","Cell Line, Tumor","Proto-Oncogene Proteins B-raf","Pyrimidinones","DNA Mutational Analysis","Humans","Melanoma","Pyridones"],"meshMinor":["GTP Phosphohydrolases","Mutation","Drug Screening Assays, Antitumor","Neurofibromin 1","Membrane Proteins","Cell Line, Tumor","Proto-Oncogene Proteins B-raf","Pyrimidinones","DNA Mutational Analysis","Humans","Melanoma","Pyridones"],"genes":["BRAF","NRAS","NF1"],"publicationTypes":["Letter","Research Support, Non-U.S. Gov\u0027t"],"title":"BRAF/NRAS wild-type melanoma, NF1 status and sensitivity to trametinib.","pubmedId":"25243813"}